Jeffrey D Capello - Net Worth and Insider Trading

Jeffrey D Capello Net Worth

The estimated net worth of Jeffrey D Capello is at least $9 Million dollars as of 2026-09-11. Jeffrey D Capello is the SVP & CFO of Revvity Inc and owns about 73,139 shares of Revvity Inc (RVTY) stock worth over $9 Million. Jeffrey D Capello is the Director of Neogen Corp and owns about 26,629 shares of Neogen Corp (NEOG) stock worth over $313,556. Jeffrey D Capello is also the EVP & CFO of Boston Scientific Corp and owns about 447 shares of Boston Scientific Corp (BSX) stock worth over $19,266. Details can be seen in Jeffrey D Capello's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey D Capello has not made any transactions after 2025-04-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jeffrey D Capello

To

Jeffrey D Capello Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey D Capello owns 8 companies in total, including Biogen Inc (BIIB) , Millendo Therapeutics Inc (MLND) , and Decoy Therapeutics Inc (DCOY) among others .

Click here to see the complete history of Jeffrey D Capello’s form 4 insider trades.

Insider Ownership Summary of Jeffrey D Capello

Ticker Company Transaction Date Type of Owner
BIIB Biogen Inc 2017-12-11 EVP & Chief Financial Officer
MLND Millendo Therapeutics Inc 2018-07-04 director
DCOY Decoy Therapeutics Inc 2015-04-01 director
LIMIT LIMIT 2013-11-27 EVP & Chief Financial Officer
LIMIT LIMIT 2007-05-31 Chief Accounting Officer
LIMIT LIMIT 2013-06-07 director
LIMIT LIMIT 2025-04-22 director
LIMIT LIMIT 2023-06-13 director

Jeffrey D Capello Latest Holdings Summary

Jeffrey D Capello currently owns a total of 3 stocks. Among these stocks, Jeffrey D Capello owns 73,139 shares of Revvity Inc (RVTY) as of May 31, 2007, with a value of $9 Million and a weighting of 96.37%. Jeffrey D Capello owns 26,629 shares of Neogen Corp (NEOG) as of April 22, 2025, with a value of $313,556 and a weighting of 3.42%. Jeffrey D Capello also owns 447 shares of Boston Scientific Corp (BSX) as of November 27, 2013, with a value of $19,266 and a weighting of 0.21%.

Latest Holdings of Jeffrey D Capello

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RVTY Revvity Inc 2007-05-31 73,139 120.94 8,845,431
NEOG Neogen Corp 2025-04-22 26,629 11.78 313,556
BSX Boston Scientific Corp 2013-11-27 447 43.10 19,266

Holding Weightings of Jeffrey D Capello


Jeffrey D Capello Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey D Capello has made a total of 0 transactions in Revvity Inc (RVTY) over the past 5 years. The most-recent trade in Revvity Inc is the sale of 37,500 shares on May 31, 2007, which brought Jeffrey D Capello around $990,000.

According to the SEC Form 4 filings, Jeffrey D Capello has made a total of 1 transactions in Neogen Corp (NEOG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Neogen Corp is the acquisition of 20,712 shares on April 22, 2025, which cost Jeffrey D Capello around $100,246.

According to the SEC Form 4 filings, Jeffrey D Capello has made a total of 0 transactions in Boston Scientific Corp (BSX) over the past 5 years. The most-recent trade in Boston Scientific Corp is the sale of 108,595 shares on November 27, 2013, which brought Jeffrey D Capello around $1 Million.

Insider Trading History of Jeffrey D Capello

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey D Capello Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey D Capello's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey D Capello is 5.68%. GuruFocus also compares Jeffrey D Capello's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey D Capello within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey D Capello's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey D Capello

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 30.32 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 19.84 LIMIT LIMIT LIMIT LIMIT LIMIT

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Jeffrey D Capello owns.
View RVTY Analysis

Jeffrey D Capello Ownership Network

Ownership Network List of Jeffrey D Capello

No Data

Ownership Network Relation of Jeffrey D Capello

Insider Network Chart


Jeffrey D Capello Owned Company Details

What does Biogen Inc do?

Who are the key executives at Biogen Inc?

Jeffrey D Capello is the EVP & Chief Financial Officer of Biogen Inc. Other key executives at Biogen Inc include Chief Legal Officer Michael Parini , Head of Pharm Ops and Tech Nicole Murphy , and Head of Development Priya Singhal .

Biogen Inc (BIIB) Insider Trades Summary

Over the past 18 months, Jeffrey D Capello made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 7,731 shares made by Priya Singhal , a net sale of 2,223 shares made by Rachid Izzar , and a net purchase of 1,235 shares made by Caroline Dorsa .

In summary, during the past 3 months, insiders sold 1,186 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 1,186 shares. During the past 18 months, 11,140 shares of Biogen Inc (BIIB) were sold and 1,238 shares were bought by its insiders, resulting in a net sale of 9,902 shares.

Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biogen Inc Insider Transactions

No Available Data

Jeffrey D Capello Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey D Capello. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jeffrey D Capello's mailing address is: Lansing Mi 48912.